
Loading, please wait...

Loading, please wait...

HLL Lifecare recently introduced its new AMRIT Plus pharmacy chain to enhance healthcare access across India. Indeed, this premium retail venture combines affordability with a superior customer experience. The public sector enterprise operates as a Mini Ratna under the Union Ministry of Health and Family Welfare. HLL Chairperson and Managing Director Dr. Anitha Thampi officially launched this flagship project during an event in Goa. Consequently, patients can now access a wider range of medical products under one trusted public brand.
To begin with, the new pharmacies offer a highly comprehensive range of health and wellness products. Specifically, consumers can purchase prescription medicines, medical devices, and nutritional supplements at competitive rates. In addition, these retail outlets will supply personal care items and lifestyle healthcare products. This expansion builds directly upon HLL's successful Affordable Medicines and Reliable Implants for Treatment (AMRIT) network. However, AMRIT Plus elevates the retail experience by introducing modern, premium storefronts. Ultimately, the organization plans to expand its total pharmacy network to over 550 outlets by December 2027.
Simultaneously, Dr. Thampi inaugurated Speciality HINDLABS to provide advanced diagnostic capabilities. This diagnostic network now offers highly specialised services including genomics, Next-Generation Sequencing, and molecular diagnostics. Furthermore, HLL has introduced Home Healthcare Services to assist patients in their own residences. This service provides skilled nursing care, post-operative support, physiotherapy, rehabilitation, and elderly care. Additionally, patients can access chronic disease management, home-based diagnostics, and teleconsultation support. Meanwhile, the HINDLABS Reference Laboratory in Kharghar, Navi Mumbai, received prestigious CAP Accreditation for its high standards. Thus, clinicians can trust the precision and quality of these clinical laboratory tests.
Apart from retail and diagnostics, HLL is expanding its emergency medical infrastructure. For instance, HLL partnered with the Government of Odisha to establish a new Trauma Care Centre. This facility, located at Panikoili in Jajpur district, will deliver comprehensive trauma and emergency care services. Therefore, patients in this region will benefit from highly responsive, phased expansion of emergency healthcare.
Q1: What is the main objective of the AMRIT Plus pharmacy chain?
Specifically, the premium pharmacy chain aims to provide a comprehensive range of medicines, medical devices, implants, and wellness products. It elevates the retail experience while maintaining affordability and quality, thereby helping reduce out-of-pocket healthcare expenses for patients across India.
Q2: What specialized services does Speciality HINDLABS offer?
Specifically, Speciality HINDLABS provides advanced diagnostic services. These include genomics, Next-Generation Sequencing (NGS), and molecular diagnostics, thereby making high-end testing more accessible and affordable.
Q3: What in-home support services does HLL Home Healthcare Services deliver?
Indeed, this initiative delivers skilled nursing care, post-operative support, physiotherapy, rehabilitation, and elderly care. Additionally, patients can access chronic disease management, in-home diagnostics, and teleconsultations.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


HLL Lifecare, a public sector enterprise under the Union Health Ministry, has launched AMRIT Plus. This premium pharmacy chain offers medical supplies and wellness products at affordable prices. Concurrently, HLL introduced Speciality HINDLABS diagnostics and comprehensive Home Healthcare Services across India.
last month

A parliamentary panel has urged the FSSAI to finalise front-of-pack nutrition labelling regulations without further delay. The committee stressed that simple, color-coded indicators for sugar and clear warning labels are vital to combat dietary non-communicable diseases and guide informed consumer choices.
3 days back

A comprehensive analysis of the NFHS-5 data regarding postpartum anemia in India, exploring the prevalence, severity, and the socioeconomic and regional factors contributing to this public health challenge for clinicians seeking to improve maternal health outcomes.
Last week

A study in Greece reveals that 46-80% of heatwave deaths are linked to climate change. This analysis explores the implications for public health and clinical practice, particularly for elderly and vulnerable populations facing rising global temperatures in regions like India.
2 weeks back

Nearly 80% of Indians suffer from inadequate Vitamin D, causing silent bone weakening and sudden fractures. This expert guide reviews why mega-dose therapy is critical for high-risk patients, the key factors driving widespread deficiency, and the mandatory medical evaluations needed to protect skeletal health.
last month

A parliamentary standing committee has directed FSSAI to expedite front-of-pack nutrition labelling regulations. The panel highlighted that over two years of delay since the 2022 draft notification leaves consumers relying on complex numerical labels, urging simple color-coded sugar indicators and warnings.
3 days back